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Basic dosimetric parameters as recommended by the AAPM Task Group No. 43 ~TG-43! have been
determined for recently available IoGold 125I brachytherapy seeds. Monte Carlo methods ~MCNP!
were used in the calculation of these parameters in water, and results compared with soon to be
published experimental parameters also for 125I IoGold seeds as well with parameters for model
6702 and 6711 125I seeds. These parameters were the radial dose function, anisotropy factor and
constant, and the dose rate constant. Using MCNP, values for the radial dose function at 0.5, 2.0,
and 5.0 cm were 1.053, 0.877, and 0.443, respectively. The anisotropy factor was 0.975, 0.946,
0.945, and 0.952 at 0.5, 1.0, 2.0, and 5.0 cm, respectively, with an anisotropy constant of 0.95. The
IoGold dose rate constant was determined by excluding the low energy titanium characteristic x
rays produced in the IoGold titanium capsule. Using this post TG-43 revised NIST air kerma
methodology, the IoGold dose rate constant was 0.96 cGy h21 U21. These calculatively determined
parameters for IoGold seeds were compared with those determined experimentally for IoGold
seeds, and also compared with parameters determined for model 6702 and 6711 seeds as presented
in TG-43. © 1998 American Association of Physicists in Medicine. @S0094-2405~98!02011-2#
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Recently, the FDA approved a new type of 125I seed, the
IoGold model 3631-A, which is produced by North Ameri-
can Scientific, Inc. Basic dosimetric properties of the IoGold
seeds have been evaluated experimentally by Wallace and
Fan1 using thermoluminescent dosimeters ~TLDs! in a tissue-
equivalent ~TE! plastic, B-material, developed at Lawrence
Livermore National Laboratory. Also, radiographic and
spectral analysis as well as QA procedures for the first batch
of IoGold seeds have been studied.2 In this paper, the dosim-
etry parameters as outlined in TG-433 have been determined
for IoGold seeds in water using MCNP.
II. MATERIALS AND METHODS
Transport calculations to determine dosimetric parameters
for the IoGold seeds were performed on our distributed
Monte Carlo N-Particle ~MCNP! system comprised of Sili-
con Graphics workstations ~R3000/R4000! and LINUX
boxes.4–6 The number of particles transported exceeded 108
in order to provide relative errors ~1 s! of less than 0.1%.
The Monte Carlo technique used herein determined en-
ergy absorbed in water within volume elements ~voxels! sur-
rounding a single IoGold seed. The 125I photon spectrum of
Browne and Firestone was used.7 Absorbed dose to water2197 Med. Phys. 25 11, November 1998 0094-2405/98/25was then determined by dividing energy absorbed by voxel
mass. Though absorbed dose was averaged within the voxel,
the size of each voxel was chosen such that the variation in
absorbed dose within the voxel did not exceed 60.2%. The
change in average absorbed dose within each voxel due to
the radiation dose gradient did not exceed 0.1%. The IoGold
seed was positioned at the center of a spherical water phan-
tom of 10 cm radius. A sampling space comprised of spheres
subdivided into conics was employed to determine the ab-
sorbed dose in each voxel.
The radial dose function, anisotropy factor, and anisot-
ropy constant were all determined in the aforementioned
spherical water phantom. The air kerma rate in free space
was calculated for derivation of the dose rate constant. Here,
the dose rate constant was determined by the ratio of the
reference dose rate to air kerma strength where the reference
dose rate is defined as the absorbed dose in water at a radius,
r, of 1 cm and an angle, u, with respect to the source long
axis, of 90 °.3 Calculation of air kerma strength was per-
formed on the transverse axis at a distance of 1 m in free
space as recommended by TG-43.3
Geometric elements of the actual source ~e.g., encapsula-
tion length, diameter, thicknesses! were modeled instead of
the more commonly employed point-wise determination.219711/2197/3/$15.00 © 1998 Am. Assoc. Phys. Med.
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Medical Physics, VTABLE I. Radial dose function, g(r), for 125I seeds.
















0.5 1.04 1.04 1.064 1.053
0.75 1.028 1.022
1.0 1.000 1.000 1.000 1.000
1.5 0.926 0.934 0.929 0.934
2.0 0.832 0.851 0.848 0.877
3.0 0.632 0.670 0.676 0.724
4.0 0.463 0.511 0.523 0.575
5.0 0.344 0.389 0.401 0.443While the three 125I seed types currently available ~IoGold,
model 6702, and model 6711! have similar external appear-
ance and are all encapsulated in titanium tubes with laser-
welded ends, there are differences within each seed type
which cause differences in their dosimetric parameters. The
model 6711 seed has Ag125I coated upon the surface of a
silver wire. The active elements of the IoGold and model
6702 seeds consist of four resin beads impregnated with 125I.
A difference between the IoGold and model 6702 125I seed is
that the laser-welded ends of the IoGold seed are 0.15 mm
compared to the 0.5 mm ends of the model 6702 seed.
Within the IoGold seed, but not within the model 6702 or
6711 seeds, are two nonradioactive spheres ~40% gold, 60%
copper! which are arranged between the 125I resin beads to
provide enhanced radiographic contrast. The gold and copper
present in the IoGold seed, the silver present in the model
6711 seed, and the titanium encapsulation present for all
seeds induce characteristic x rays. Consequently, differences
in the dosimetric parameters for these three 125I seeds are
expected. The TE plastic phantom material used by Wallace
and Fang1 was comprised of H, C, N, O, and Ca ~0.78%
mass! with a mass density of 1.09 g/cm3.
III. RESULTS AND DISCUSSION
A. Radial dose function
The radial dose function, g(r), was calculated and
experimentally1 determined for radii of 0.5 to 5.0 cm for
IoGold seeds. These results are presented in Table I in addi-
tion to those experimentally determined and recommended
by TG-433 for 125I model 6702 and 6711. Results of MCNP
calculations were greater than the experimental results1 for
IoGold seeds by up to 10% at a distance of 5.0 cm. This may
be due to the differences between water and TE plastic, since
decreased attenuation is expected in the water phantom due
to the presence of calcium in the TE plastic which increases
the 125I attenuation due to the photoelectric effect. In a
Monte Carlo simulation study by Meigooni et al.,8 values for
g(r), as recommended by TG-43,3 were also determined in
Solid Water, and similarly demonstrated a decrease in g(r)
values compared with our results determined in water for
radii exceeding 1 cm, probably due to the photoelectric ef-ol. 25, No. 11, November 1998fect of calcium. Our calculated coefficient values for radial
dose function results in water are fitted to a 5th order poly-





The impact of the Au/Cu spheres is not expected to signifi-
cantly alter the radial dose function.
B. Anisotropy factors and constants
Anisotropy factors, fan(r), for several radii were deter-
mined through calculation of absorbed dose to water be-
tween two spherical shells enclosing the source, and dividing
these values by the transverse axis absorbed dose; the aver-
age dose rate for a given radius was normalized to that on the
transverse axis where r is the radius and u0 is 90 ° on the





Table II presents the calculative results determined for the
IoGold seeds, as well as experimental results1 for IoGold
seeds and experimentally determined TG-433 recommended
values for model 6702 and 6711 125I seeds. Only the calcu-
lated results for IoGold seeds were determined in water,
while all other results in Table II were determined in TE
plastic1 or Solid Water.3 In comparing the anisotropy factors
determined experimentally with those determined calcula-
tively, it is clear that there is greater fluctuation in the results
determined experimentally.
From Table II, it is evident the variation of the experi-
mentally measured anisotropy factors1,3 is more for the
IoGold and model 6702 seeds than that of the model 6711
seed. As the location of the Au/Cu spheres and 125I resin
beads within the IoGold seeds have been shown2 to move,
this variability in position may have complicated experimen-
tal measurements of the anisotropy factors for IoGold and
model 6711 125I seeds. However, the differences between the
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1.0 0.944 0.968 0.885 0.946
1.5 0.951
2.0 0.936 0.928 0.847 0.945
3.0 0.893 0.897 0.926 0.947
4.0 0.887 0.942 0.853 0.951
5.0 0.884 0.959 0.936 0.952
Anisotropy
constants fan 0.93 0.95 0.90 0.95calculative and experimentally1 determined anisotropy fac-
tors are primarily attributed to variation in TLD response.
Here, measurements using radiation-sensitive film may re-
solve this discrepancy.
A value of 0.95 was calculated for the anisotropy con-
stant, fan(r), which is about 5% greater than that, 0.90, de-
termined experimentally using TLDs.1 The anisotropy con-
stants for 125I model 6702 and 6711 are also presented in
Table II. While the calculated IoGold anisotropy constant
was identical to that of the model 6702 125I seed,3 direct
comparison of fan(r) between the three seed types is of
limited utility due to their dissimilar construction.
C. Dose rate constant
While the low energy, approximately 4 keV, titanium
characteristic x rays from the 125I encapsulation contribute to
measurements of air kerma strength, they are relatively in-
nocuous for in vivo dosimetry. Consequently, absorbed dose
from these x rays was disregarded in calculation of the ref-
erence dose rate and also in calculation of air kerma strength
in adherence to post TG-43 125I NIST calibration methods.10
The dose rate constant calculated in such a way is 0.96
cGy h21 U21, but would be about 0.86 cGy h21 U21, ap-
proximately 10% less, if calculated using the previous ~1985!
NIST methodology.10 The dose rate constant determined ex-
perimentally by Wallace and Fan1 was 0.93 cGy h21 U21. As
the experimentally determined dose rate constant employed
the 1985 NIST methodology, the MCNP calculated dose rate
constant ~0.86 cGy h21 U21! using the 1985 NIST
methodology10 was about 7% less than that ~0.93
cGy h21 U21! determined experimentally.1 For comparative
purposes, the revised dose rate constants for models 6702
and 6711 125I seeds are 0.93 cGy h21 U21 and 0.88
cGy h21 U21, respectively.10 Quantitative comparison be-
tween the dose rate constant values of the three seed types
~IoGold, model 6702, and 6711! is complicated by their dif-
fering construction ~e.g., Au/Cu beads, Ag wire, encapsula-
tion thickness!.ol. 25, No. 11, November 1998IV. CONCLUSION
We recommend use of the 125I IoGold dosimetry param-
eters determined herein as they were calculated in water us-
ing MCNP in strict adherence to TG-43 recommendations,
and in accordance with the recently revised NIST 125I source
calibration methodology.3,10 While these results should be
confirmed with experimental measurements, the purpose of
these calculations was to provide reference dosimetry param-
eters for IoGold 125I seeds necessary for clinical treatment
planning of interstitial brachytherapy implants.
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